Literature DB >> 20606424

Presence of deep white matter lesions on diffusion-weighted imaging is a negative predictor of early dramatic improvement after intravenous tissue plasminogen activator thrombolysis.

Hiroyuki Kawano1, Teruyuki Hirano, Yuichiro Inatomi, Tadashi Terasaki, Toshiro Yonehara, Makoto Uchino.   

Abstract

BACKGROUND: The impact of deep white matter lesions observed at the corona radiata on diffusion-weighted MRI (DWI-W lesions) on the clinical recovery of patients after tissue plasminogen activator (tPA) therapy is unclear. Our goal was to elucidate whether DWI findings before tPA could predict clinical recovery.
METHODS: A total of 83 consecutive patients with hyperacute anterior circulation ischemic stroke were enrolled. All patients underwent MRI within 3 h and received intravenous tPA. The relationships among the Alberta Stroke Program Early CT Score (ASPECTS) on DWI (DWI-ASPECTS), DWI-W lesions, early dramatic improvement (> or =10-point reduction in the total National Institutes of Health Stroke Scale, NIHSS, score or a total NIHSS score of 0-2 after 24 h), early improvement (> or =4-point reduction in the total NIHSS score after 24 h) and worsening (> or =4-point increase in the total NIHSS score after 24 h) were assessed.
RESULTS: The median of the baseline DWI-ASPECTS value was 9 (range: 5-10), and DWI-W lesions were found in 36 patients (43%). Patients with early dramatic improvement had a shorter time from onset to tPA (116.1 +/- 34.9 vs. 133.2 +/- 33.1 min; p = 0.0281) and higher DWI-ASPECTS (medians: 9 vs. 9; p = 0.0568). DWI-W lesions were seen less frequently in patients with than without early dramatic improvement (26 vs. 54%; p = 0.0213). Multivariate logistic regression analysis demonstrated that absence of DWI-W lesions (OR: 1.80; 95% CI: 1.08-3.13; p = 0.0279), higher ASPECTS (OR: 1.56; 95% CI: 1.06-2.46; p = 0.0346) and shorter time from onset to tPA (OR: 0.98; 95% CI: 0.97-0.99; p = 0.0429) were independent predictors of early dramatic improvement.
CONCLUSIONS: DWI-ASPECTS and DWI-W lesions appear to be useful tools for predicting early dramatic improvement. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20606424     DOI: 10.1159/000317183

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  6 in total

1.  Large deep white matter lesions may predict futile recanalization in endovascular therapy for acute ischemic stroke.

Authors:  Yohei Tateishi; Dolora Wisco; Junya Aoki; Pravin George; Irene Katzan; Gabor Toth; Ferdinand Hui; Muhammad S Hussain; Ken Uchino
Journal:  Interv Neurol       Date:  2015-01

2.  Inter-rater reliability of modified Alberta Stroke program early computerized tomography score in patients with brain infarction.

Authors:  Kavian Ghandehari; Mohammad Reza Rezvani; Mohammad Taghi Shakeri; Mahdi Mohammadifard; Alireza Ehsanbakhsh; Mahyar Mohammadifard; Alireza Mirgholami; Reza Boostani; Kosar Ghandehari; Zahra Izadi-Mood
Journal:  J Res Med Sci       Date:  2011-10       Impact factor: 1.852

3.  Modified ASPECTS for DWI including deep white matter lesions predicts subsequent intracranial hemorrhage.

Authors:  Hiroyuki Kawano; Teruyuki Hirano; Makoto Nakajima; Yuichiro Inatomi; Toshiro Yonehara; Makoto Uchino
Journal:  J Neurol       Date:  2012-02-17       Impact factor: 4.849

4.  Long-Term Outcomes of FIM Motor Items Predicted From Acute Stage NIHSS of Patients With Middle Cerebral Artery Infarct.

Authors:  Jun Saito; Tetsuo Koyama; Kazuhisa Domen
Journal:  Ann Rehabil Med       Date:  2018-10-31

5.  Assessment of veins in T2*-weighted MR angiography predicts infarct growth in hyperacute ischemic stroke.

Authors:  Susumu Yamaguchi; Nobutaka Horie; Minoru Morikawa; Yohei Tateishi; Takeshi Hiu; Yoichi Morofuji; Tsuyoshi Izumo; Kentaro Hayashi; Takayuki Matsuo
Journal:  PLoS One       Date:  2018-04-04       Impact factor: 3.240

6.  Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke.

Authors:  Dae-Hyun Kim; Deok-Soo Lee; Hyun-Wook Nah; Jae-Kwan Cha
Journal:  BMC Neurol       Date:  2018-03-15       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.